GMO Prime Strategy Co.,Ltd. Revises Earnings Forecast — Revenue Up 9.2%
GMO Prime Strategy Co.,Ltd. (TSE:5250) has revised its earnings forecast for the period ending December 31, 2026, due to an extended accounting period of 13 months.
| Item | Before | After | Change |
|---|---|---|---|
| Revenue | JPY 1.03bn | JPY 1.12bn | +9.2% |
| Operating Profit | JPY 61M | JPY 70M | +14.8% |
| Ordinary Income | JPY 62M | JPY 72M | +16.1% |
| Net Profit | JPY 45M | JPY 51M | +13.3% |
| EPS | JPY 12.87/share | JPY 14.77/share | +JPY 1.90/share |
The revision stems from a change in the fiscal year-end, extending the reporting period from 12 to 13 months. Previously, the forecast covered the 12-month period ending November 30, 2026, but the new forecast spans December 1, 2025, to December 31, 2026. This adjustment aims to reflect the full 13-month fiscal performance.
The change in the accounting period does not indicate a shift in underlying performance but rather a realignment of the forecast timeline. Investors should note that the revised figures cover an additional month compared to the prior forecast, which may affect comparability. When evaluating the numbers, it is essential to consider the difference in reporting periods to avoid misinterpretation.
Source: Original filing (TDnet) | 日本語版
This article is for informational purposes only and does not constitute investment advice. Always verify against the original filing.